Paper Details
- Home
- Paper Details
Doxorubicin and streptozotocin after failed biotherapy of neuroendocrine tumors.
Author: BaumUlrich, HahnEckhart G, HensenJohannes, PavelMarianne E
Original Abstract of the Article :
Well-differentiated neuroendocrine tumors are treated primarily with somatostatin analogs and interferon-alpha. It is not clear what therapy should be applied after failed biotherapy. Our aim was to establish whether patients whose tumors rapidly progress under biotherapy may benefit from chemothera...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1385/IJGC:35:3:179
データ提供：米国国立医学図書館（NLM）
Beyond Biotherapy: Exploring Chemotherapy for Neuroendocrine Tumors
Neuroendocrine tumors, a group of rare and complex cancers, often resist conventional therapies. This research delves into the potential of using chemotherapy, specifically a combination of doxorubicin and streptozotocin, as a treatment option for patients with neuroendocrine tumors who have not responded to biotherapy. The authors explore the potential benefits and limitations of using this approach, focusing on its effectiveness in cases where biotherapy has failed.
A New Avenue for Treatment: Chemotherapy Shows Promise in Neuroendocrine Tumors
The study suggests that chemotherapy, using a combination of doxorubicin and streptozotocin, may be a viable treatment option for patients with neuroendocrine tumors who have not responded to biotherapy. The research indicates that this approach might offer a potential benefit for patients whose tumors have progressed rapidly under biotherapy, providing a promising new avenue for treatment in this challenging area.
Navigating the Complexity: Understanding the Potential and Limitations
This research highlights the need for further investigation into the use of chemotherapy for neuroendocrine tumors. The findings suggest potential benefits, but also emphasize the importance of careful consideration of individual patient factors and potential side effects. The study underscores the complexities of treating neuroendocrine tumors, highlighting the importance of ongoing research and a personalized approach to treatment.
Dr.Camel's Conclusion
This research is like a desert oasis, offering a potential lifeline for patients with neuroendocrine tumors who have not responded to biotherapy. The findings highlight the importance of exploring new treatment avenues, even in the challenging realm of rare and complex cancers. Just as an oasis offers respite in a harsh desert environment, this research provides a glimmer of hope for patients battling neuroendocrine tumors.
Date :
- Date Completed 2005-12-07
- Date Revised 2018-11-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.